In January 2022, Tracey Kassman, then 64 years previous, confronted the truth that her life could also be ending prior to anticipated. She was recognized with glioblastoma after medical doctors uncovered a mind tumor. Glioblastoma has a mean life expectancy of 12-18 months.
“I had kind of made peace with the concept that it is a terminal sickness, however I additionally realized that there was an entire lot of different stuff that I needed to do,” stated Tracey.
Tracey underwent radiation and chemotherapy at Roswell Park Complete Most cancers Heart. Then, to her shock, that April, she was offered with another choice.
“Dr. Chinazom Ibegbu, who I am keen on by the best way, stated, ‘I believe you’d be candidate for this vaccine that we’re operating trials on. Would you be taken with collaborating?’ And I used to be like, ‘Let’s see … It’s a extremely unhealthy prognosis if I don’t do something, so let’s simply do all the pieces we probably can to attempt to be sure that I’ve extra birthdays.”
And so, Tracey enrolled within the double-blind SurVaxM scientific trial. That was three years in the past.
